Galera Therapeutics (GRTX) News Today $0.12 0.00 (0.00%) (As of 07/26/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 November 2021 October 2021 September 2021 August 2021 Time Period July 23 at 7:16 PM | nasdaq.comGalera Therapeutics, Inc. Common Stock (GRTX)May 13, 2024 | globenewswire.comGalera Reports First Quarter 2024 Financial Results and Recent Corporate UpdatesMay 3, 2024 | finanznachrichten.deGalera Therapeutics: Galera Adopts Limited Duration Stockholder Rights AgreementMay 3, 2024 | globenewswire.comGalera Adopts Limited Duration Stockholder Rights AgreementApril 1, 2024 | msn.comGalera Therapeutics Seeks Strategic Alternatives Amid Financial Setbacks and Regulatory ChallengesMarch 28, 2024 | finanznachrichten.deGalera Therapeutics: Galera Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Corporate UpdatesMarch 28, 2024 | globenewswire.comGalera Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Corporate UpdatesMarch 16, 2024 | finance.yahoo.comGRTX Apr 2024 0.500 callMarch 12, 2024 | nz.finance.yahoo.comGalera Therapeutics, Inc. (GRTX)February 27, 2024 | edition.cnn.comGalera Therapeutics, Inc.February 4, 2024 | investing.comGalera Therapeutics Inc (GRTX)February 4, 2024 | benzinga.comGalera Therapeutics Stock (NASDAQ:GRTX) Dividends: History, Yield and DatesJanuary 21, 2024 | finance.yahoo.comGalera Therapeutics Insiders Lose Out As Stock Sinks To US$0.17January 16, 2024 | bizjournals.comLocal publicly traded stocks lag far behind national indices in 2023January 9, 2024 | msn.comDow Tumbles Over 200 Points; US Trade Gap Narrows In NovemberNovember 28, 2023 | msn.comGalera Therapeutics (GRTX) Price Target Increased by 7.14% to 0.38November 14, 2023 | finanznachrichten.deGalera Therapeutics: Galera Reports Third Quarter 2023 Financial Results and Recent Corporate UpdatesNovember 14, 2023 | benzinga.comGalera Therapeutics: Q3 Earnings InsightsNovember 14, 2023 | finance.yahoo.comGalera Reports Third Quarter 2023 Financial Results and Recent Corporate UpdatesNovember 13, 2023 | benzinga.comGalera Therapeutics's Earnings OutlookNovember 1, 2023 | benzinga.comUS Stocks Fall; Pfizer Swings To Q3 LossOctober 31, 2023 | benzinga.comDow Gains 50 Points; Global Payments Posts Upbeat EarningsOctober 31, 2023 | bizjournals.comGalera Therapeutics warns of potential shutdown as it halts clinical trials and stock tanksOctober 31, 2023 | msn.comWhy Is Cancer Focused Galera Therapeutics Stock Sinking Today?October 31, 2023 | msn.comGalera plunges after citing risks to business continuityOctober 31, 2023 | finanznachrichten.deGalera Therapeutics: Galera Announces Receipt of Type A Meeting Minutes and Strategic UpdateOctober 31, 2023 | finance.yahoo.comGalera Announces Receipt of Type A Meeting Minutes and Strategic UpdateOctober 31, 2023 | marketbeat.comTrading was temporarily halted for "GRTX" at 06:10 AM with a stated reason of "News pending."September 19, 2023 | markets.businessinsider.comGalera Therapeutics (GRTX) Gets a Hold from H.C. WainwrightSeptember 18, 2023 | finance.yahoo.comGalera Schedules Type A Meeting with FDA to Discuss Next Steps for AvasopasemSeptember 5, 2023 | finance.yahoo.comGalera to Participate in the H.C. Wainwright 25th Annual Global Investment ConferenceAugust 30, 2023 | markets.businessinsider.comCiti Sticks to Its Hold Rating for Galera Therapeutics (GRTX)August 30, 2023 | nasdaq.comCitigroup Maintains Galera Therapeutics (GRTX) Neutral RecommendationAugust 29, 2023 | markets.businessinsider.comExpert Ratings for Galera TherapeuticsAugust 16, 2023 | markets.businessinsider.comH.C. Wainwright downgrades Galera Therapeutics (GRTX) to a HoldAugust 14, 2023 | finance.yahoo.comGalera Reports Second Quarter 2023 Financial Results and Recent Corporate UpdatesAugust 11, 2023 | msn.comGalera cut to Underperform at BofA after FDA snub for lead assetAugust 10, 2023 | msn.comWhy Is Galera Therapeutics Stock Sinking Today?August 10, 2023 | finance.yahoo.comGalera shares plunge 85% on FDA rejection; workforce cut by more than halfAugust 10, 2023 | finanznachrichten.deGalera Therapeutics: Galera Receives Complete Response Letter from U.S. FDA for Avasopasem ManganeseAugust 10, 2023 | markets.businessinsider.comGalera Gets CRL From FDA For Avasopasem Manganese, To Cut 70% Jobs; Stock Down In PremarketAugust 9, 2023 | msn.comFDA rejects Galera's treatment for mouth sores in cancer patients, stock -83% after hoursAugust 9, 2023 | finance.yahoo.comGalera Receives Complete Response Letter from U.S. FDA for Avasopasem ManganeseAugust 9, 2023 | finance.yahoo.comGalera shares tank after US FDA declines to approve inflammation disease drugAugust 9, 2023 | marketbeat.comTrading was temporarily halted for "GRTX" at 04:08 PM with a stated reason of "News pending."July 27, 2023 | uk.finance.yahoo.comGRTX - Galera Therapeutics, Inc.July 17, 2023 | bizjournals.comSt. Louis stocks have fallen behind major indices this yearJuly 17, 2023 | markets.businessinsider.comAnalysts Are Bullish on Top Healthcare Stocks: Galera Therapeutics (GRTX), Acumen Pharmaceuticals (ABOS)June 28, 2023 | finance.yahoo.comDespite Galera Therapeutics' Pullback, Insiders Still Gained US$102kJune 6, 2023 | markets.businessinsider.comPiper Sandler Remains a Buy on Galera Therapeutics (GRTX) Get Galera Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for GRTX and its competitors with MarketBeat's FREE daily newsletter. Email Address Nvidia insiders dumping shares (Ad)All the signs show the AI market is about to reverse. And unless you know what’s really going on in this sector, you could be wiped out. Inside this new expose, you'll discover exactly how the AI crisis will unfold... how you can prepare for it before it's too late... and how you can potentially profit from it, too. Click here to read the new expose, The Big AI Die-Up while you still can. To see Porter Stansberry's new AI prediction go here now. GRTX Media Mentions By Week GRTX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. GRTX News Sentiment▼0.000.62▲Average Medical News Sentiment GRTX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. GRTX Articles This Week▼10▲GRTX Articles Average Week Get Galera Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for GRTX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: ENLV News Today AKTX News Today BOLT News Today CLNN News Today RNXT News Today ACST News Today NRXP News Today NNVC News Today UBX News Today ORGS News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:GRTX) was last updated on 7/26/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredThis student turned $1,300 into $45,000 in just 4 Months!With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... ...Monument Traders Alliance | SponsoredCollapse of the PetrodollarThe death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Ru...Colonial Metals | SponsoredRare signal predicts 50% market drop - before electionThe market is near all-time highs, we're told that unemployment is low, AI's a gift to humanity, and the FED w...Behind the Markets | SponsoredMust-See: Elon’s New Invention is Absolutely InsaneCould Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | SponsoredElon to Transform U.S. Economy? A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” ...Porter & Company | Sponsored5 Stocks that could triple in a week Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Galera Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Galera Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free GRTX Stock Alerts